• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中LRRK2变异体临床和基因谱的最新MDSGene综述。

Updated MDSGene review on the clinical and genetic spectrum of LRRK2 variants in Parkinson´s disease.

作者信息

Krüger Clara, Lim Shen-Yang, Buhrmann Alissa, Fahrig Fenja L, Gabbert Carolin, Bahr Natascha, Madoev Harutyun, Marras Connie, Klein Christine, Lohmann Katja

机构信息

Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.

Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

出版信息

NPJ Parkinsons Dis. 2025 Feb 17;11(1):30. doi: 10.1038/s41531-025-00881-9.

DOI:10.1038/s41531-025-00881-9
PMID:39962078
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11832785/
Abstract

Pathogenic variants in the LRRK2 gene are one of the most commonly identifiable monogenic causes of Parkinson´s disease (PD, PARK-LRRK2). This systematic MDSGene literature review comprehensively summarizes published demographic, clinical, and genetic findings related to LRRK2 variants ( https://www.mdsgene.org/ ). Data on 4660 individuals with 283 different variants were curated. The median age at onset in the PD patients with available information was 56 years, notably, with approximately one-third having PD onset <50 years. Tremor was the most frequently reported initial symptom and more common than reported in other dominantly inherited forms of PD. Of the 211 potentially PD-causing variants, 25 were classified as pathogenic or likely pathogenic, and the remaining 186 (88.2%) were variants of uncertain significance. p.G2019S was the most frequently reported pathogenic variant, followed by p.R1441G and p.R1441C. This systematic review represents the most extensive database on PARK-LRRK2 to date and provides a vital resource to improve precision medicine.

摘要

亮氨酸富集重复激酶2(LRRK2)基因的致病性变异是帕金森病(PD,PARK-LRRK2)最常见的可识别单基因病因之一。这项系统的MDSGene文献综述全面总结了已发表的与LRRK2变异相关的人口统计学、临床和遗传学研究结果(https://www.mdsgene.org/)。整理了4660名携带283种不同变异个体的数据。有可用信息的PD患者的发病年龄中位数为56岁,值得注意的是,约三分之一的患者在50岁之前发病。震颤是最常报告的初始症状,比其他显性遗传形式的PD更常见。在211种可能导致PD的变异中,25种被分类为致病性或可能致病性,其余186种(88.2%)为意义未明的变异。p.G2019S是最常报告的致病性变异,其次是p.R1441G和p.R1441C。这项系统综述是迄今为止关于PARK-LRRK2最广泛的数据库,为改善精准医学提供了重要资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5819/11832785/f2786f0dd20e/41531_2025_881_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5819/11832785/a3796aa5f670/41531_2025_881_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5819/11832785/afa1b7bfa4b5/41531_2025_881_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5819/11832785/b727d2d6131d/41531_2025_881_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5819/11832785/0ef242d01b57/41531_2025_881_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5819/11832785/a6617b059f8d/41531_2025_881_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5819/11832785/f2786f0dd20e/41531_2025_881_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5819/11832785/a3796aa5f670/41531_2025_881_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5819/11832785/afa1b7bfa4b5/41531_2025_881_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5819/11832785/b727d2d6131d/41531_2025_881_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5819/11832785/0ef242d01b57/41531_2025_881_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5819/11832785/a6617b059f8d/41531_2025_881_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5819/11832785/f2786f0dd20e/41531_2025_881_Fig6_HTML.jpg

相似文献

1
Updated MDSGene review on the clinical and genetic spectrum of LRRK2 variants in Parkinson´s disease.帕金森病中LRRK2变异体临床和基因谱的最新MDSGene综述。
NPJ Parkinsons Dis. 2025 Feb 17;11(1):30. doi: 10.1038/s41531-025-00881-9.
2
MDSGene: Closing Data Gaps in Genotype-Phenotype Correlations of Monogenic Parkinson's Disease.MDSGene:填补单基因帕金森病基因型-表型相关性中的数据空白。
J Parkinsons Dis. 2018;8(s1):S25-S30. doi: 10.3233/JPD-181505.
3
Genotype-phenotype relations for the Parkinson's disease genes SNCA, LRRK2, VPS35: MDSGene systematic review.帕金森病基因 SNCA、LRRK2、VPS35 的基因型-表型关系:MDSGene 系统评价。
Mov Disord. 2018 Dec;33(12):1857-1870. doi: 10.1002/mds.27527. Epub 2018 Oct 24.
4
LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.西班牙帕金森病患者的LRRK2突变:频率、临床特征及不完全外显率
Arch Neurol. 2006 Mar;63(3):377-82. doi: 10.1001/archneur.63.3.377.
5
Genetics of Parkinson's Disease: From Causes to Treatment.帕金森病的遗传学:从病因到治疗
Cold Spring Harb Perspect Med. 2024 Aug 12. doi: 10.1101/cshperspect.a041774.
6
Clinical characterization of patients with leucine-rich repeat kinase 2 genetic variants in Japan.日本富亮氨酸重复激酶 2 基因突变患者的临床特征。
J Hum Genet. 2020 Sep;65(9):771-781. doi: 10.1038/s10038-020-0772-4. Epub 2020 May 13.
7
Clinical Phenotype of LRRK2 R1441C in 2 Chinese Sisters.LRRK2 R1441C 在中国 2 姐妹中的临床表型。
Neurodegener Dis. 2020;20(1):39-45. doi: 10.1159/000508131. Epub 2020 Jun 24.
8
Classification and Genotype-Phenotype Relationships of GBA1 Variants: MDSGene Systematic Review.GBA1基因变异的分类及基因型-表型关系:MDSGene系统评价
Mov Disord. 2025 Apr;40(4):605-618. doi: 10.1002/mds.30141. Epub 2025 Feb 10.
9
Identification of LRRK2 missense variants in the accelerating medicines partnership Parkinson's disease cohort.在加速药物合作帕金森病队列中鉴定 LRRK2 错义变异。
Hum Mol Genet. 2021 Apr 30;30(6):454-466. doi: 10.1093/hmg/ddab058.
10
Genetic screening for the LRRK2 R1441C and G2019S mutations in Parkinsonian patients from Campania.对坎帕尼亚地区帕金森病患者进行LRRK2基因R1441C和G2019S突变的基因筛查。
J Parkinsons Dis. 2014;4(1):123-8. doi: 10.3233/JPD-130312.

引用本文的文献

1
Leucine-rich repeat kinase 2 biomarkers for Parkinson's disease.帕金森病的富含亮氨酸重复激酶2生物标志物。
Biochem J. 2025 May 28;482(11):BCJ20253099. doi: 10.1042/BCJ20253099.
2
Clinical and functional evidence for the pathogenicity of the LRRK2 p.Arg1067Gln variant.LRRK2基因p.Arg1067Gln变异致病性的临床和功能证据。
NPJ Parkinsons Dis. 2025 Feb 23;11(1):34. doi: 10.1038/s41531-025-00884-6.
3
Classification and Genotype-Phenotype Relationships of GBA1 Variants: MDSGene Systematic Review.GBA1基因变异的分类及基因型-表型关系:MDSGene系统评价
Mov Disord. 2025 Apr;40(4):605-618. doi: 10.1002/mds.30141. Epub 2025 Feb 10.

本文引用的文献

1
LRRK2 Inhibitors as Promising Treatment for Parkinson's Disease.LRRK2 抑制剂有望成为治疗帕金森病的新方法。
ACS Chem Neurosci. 2024 Nov 20;15(22):4092-4094. doi: 10.1021/acschemneuro.4c00657. Epub 2024 Nov 2.
2
Uncovering the genetic basis of Parkinson's disease globally: from discoveries to the clinic.全球范围内帕金森病的遗传基础研究:从发现到临床应用。
Lancet Neurol. 2024 Dec;23(12):1267-1280. doi: 10.1016/S1474-4422(24)00378-8. Epub 2024 Oct 21.
3
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study.基因靶向试验时代基因检测的相关性:罗斯托克帕金森病研究
Brain. 2024 Aug 1;147(8):2652-2667. doi: 10.1093/brain/awae188.
4
Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.帕金森病变异检测与披露:北美研究项目“PD基因计划”
Brain. 2024 Aug 1;147(8):2668-2679. doi: 10.1093/brain/awae142.
5
Genetic landscape of Parkinson's disease and related diseases in Luxembourg.卢森堡帕金森病及相关疾病的遗传图谱
Front Aging Neurosci. 2023 Dec 20;15:1282174. doi: 10.3389/fnagi.2023.1282174. eCollection 2023.
6
A Next-Generation Sequencing Study in a Cohort of Sicilian Patients with Parkinson's Disease.一项针对西西里岛帕金森病患者队列的二代测序研究。
Biomedicines. 2023 Nov 22;11(12):3118. doi: 10.3390/biomedicines11123118.
7
Genetic overlap between ALS and other neurodegenerative or neuromuscular disorders.肌萎缩侧索硬化症与其他神经退行性或神经肌肉疾病之间的遗传重叠。
Amyotroph Lateral Scler Frontotemporal Degener. 2024 Feb;25(1-2):177-187. doi: 10.1080/21678421.2023.2270705. Epub 2024 Jan 23.
8
Rapidly progressive multiple system atrophy in a patient carrying LRRK2 G2019S mutation.携带 LRRK2 G2019S 突变的快速进行性多系统萎缩患者。
Neurol Sci. 2024 Jan;45(1):309-313. doi: 10.1007/s10072-023-07056-5. Epub 2023 Sep 27.
9
Interaction of Mitochondrial Polygenic Score and Lifestyle Factors in LRRK2 p.Gly2019Ser Parkinsonism.线粒体多基因风险评分与 LRRK2 p.Gly2019Ser 帕金森病患者生活方式因素的相互作用。
Mov Disord. 2023 Oct;38(10):1837-1849. doi: 10.1002/mds.29563. Epub 2023 Jul 21.
10
Elucidating causative gene variants in hereditary Parkinson's disease in the Global Parkinson's Genetics Program (GP2).在全球帕金森病遗传学项目(GP2)中阐明遗传性帕金森病的致病基因变异。
NPJ Parkinsons Dis. 2023 Jun 27;9(1):100. doi: 10.1038/s41531-023-00526-9.